Company intelligence / Profile preview

AquaCap Pharmaceutical

Coral Springs, Florida, USA

Ownership: Private
Development stage: Other

Overview

AquaCap Pharmaceutical is a specialized contract manufacturing organization (CMO) focused on the development and manufacture of liquid-filled hard capsules (LFHC). The company provides proprietary technology for sealing and stabilizing liquid formulations within hard gelatin or hydroxypropyl methylcellulose (HPMC) capsules, catering to both the pharmaceutical and nutraceutical industries. AquaCap's expertise addresses complex formulation challenges such as bioavailability enhancement, low-dose uniformity, and the delivery of lipid-based compounds. Following its acquisition by Capsugel (now part of Lonza), its technologies have been integrated into a global portfolio of advanced drug delivery solutions.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on AquaCap Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AquaCap Pharmaceutical.

Explore the full profile